Drugs Considered Breakthrough Therapies

February 2, 2015

Slide
Slide
Slide
Slide
Slide
Slide
Slide
Slide
Slide

In 2014 the FDA designated nine novel drugs as Breakthrough therapies, in which preliminary clinical evidence demonstrates that the drug may result in substantial improvement on at least one clinically significant endpoint over other available therapies.

Slideshow

Slide

Slide

Slide

Slide

Slide

Slide

Slide

Slide

Slide

Want to read more?